U.S. Dementia Treatment Market, 2026-2033

Name: U.S. Dementia Treatment Market
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The dementia treatment market in the United States is expected to reach a projected revenue of US$ 9,912.1 million by 2033. A compound annual growth rate of 6.7% is expected of the United States dementia treatment market from 2026 to 2033.

U.S. dementia treatment report indication outlook (Revenue, USD million, 2021-2033)
- Alzheimer’s Disease Dementia
- Vascular Dementia
- Lewy Body Dementia
- Frontotemporal Dementia (FTD)
- Parkinson Disease Dementia
- Other Indications
U.S. dementia treatment report drug class outlook (Revenue, USD million, 2021-2033)
- Cholinesterase Inhibitors
- NMDA Receptor Antagonist
- MAO Inhibitors
- Combination Drug
- Other Drug Classes
U.S. dementia treatment report route of administration outlook (Revenue, USD million, 2021-2033)
- Oral
- Transdermal Patch
- Injectable
U.S. dementia treatment report distribution channel outlook (Revenue, USD million, 2021-2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy

U.S. Dementia Treatment Market, 2026-2033

Sign up - it's easy, and free!